Integrating Genome and Methylome Data to Identify Candidate DNA Methylation Biomarkers for Pancreatic Cancer Risk

Background: The role of methylation in pancreatic cancer risk remains unclear. We integrated genome and methylome data to identify CpG sites (CpG) with the genetically predicted methylation to be associated with pancreatic cancer risk. We also studied gene expression to understand the identified associations. Methods: Using genetic data and white blood cell methylation data from 1,595 subjects of European descent, we built genetic models to predict DNA methylation levels. After internal and external validation, we applied prediction models with satisfactory performance to the genetic data of 8,280 pancreatic cancer cases and 6,728 controls of European ancestry to investigate the associations of predicted methylation with pancreatic cancer risk. For associated CpGs, we compared their measured levels in pancreatic tumor versus benign tissue. Results: We identified 45 CpGs at nine loci showing an association with pancreatic cancer risk, including 15 CpGs showing an association independent from identified risk variants. We observed significant correlations between predicted methylation of 16 of the 45 CpGs and predicted expression of eight adjacent genes, of which six genes showed associations with pancreatic cancer risk. Of the 45 CpGs, we were able to compare measured methylation of 16 in pancreatic tumor versus benign pancreatic tissue. Of them, six showed differentiated methylation. Conclusions: We identified methylation biomarker candidates associated with pancreatic cancer using genetic instruments and added additional insights into the role of methylation in regulating gene expression in pancreatic cancer development. Impact: A comprehensive study using genetic instruments identifies 45 CpG sites at nine genomic loci for pancreatic cancer risk.

[1]  K. D. Sørensen,et al.  An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk , 2020, Nature Communications.

[2]  Geoffrey S. Tobias,et al.  A Transcriptome-Wide Association Study (TWAS) Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. , 2020, Journal of the National Cancer Institute.

[3]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[4]  Andrew D. Johnson,et al.  Genome-wide identification of DNA methylation QTLs in whole blood highlights pathways for cardiovascular disease , 2019, Nature Communications.

[5]  Bogdan Pasaniuc,et al.  Identification of novel susceptibility loci and genes for prostate cancer risk: A transcriptome-wide association study in over 140,000 European descendants. , 2019, Cancer research.

[6]  K. Muir,et al.  Genetically predicted levels of DNA methylation biomarkers and breast cancer risk: data from 228,951 women of European descent. , 2019, Journal of the National Cancer Institute.

[7]  W. Bamlet,et al.  Analysis of Heritability and Genetic Architecture of Pancreatic Cancer: A PanC4 Study , 2019, Cancer Epidemiology, Biomarkers & Prevention.

[8]  L. Wood,et al.  Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood , 2019, Clinical Epigenetics.

[9]  David A. Knowles,et al.  Opportunities and challenges for transcriptome-wide association studies , 2019, Nature Genetics.

[10]  W. Willett,et al.  Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk. , 2018, Cancer research.

[11]  Jeffery M. Meyer,et al.  A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer , 2018, Nature Genetics.

[12]  Peter Kraft,et al.  Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer , 2018, Nature Communications.

[13]  Mary Goldman,et al.  Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics , 2016, Nature Communications.

[14]  X. Hua,et al.  Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers , 2017, Human molecular genetics.

[15]  R. Marioni,et al.  Identification of 55,000 Replicated DNA Methylation QTL , 2017, Scientific Reports.

[16]  P. Bugert,et al.  HYAL2 methylation in peripheral blood as a potential marker for the detection of pancreatic cancer: a case control study , 2017, Oncotarget.

[17]  T. Luedde,et al.  Current and future biomarkers for pancreatic adenocarcinoma , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[18]  Alison P. Klein,et al.  Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21 , 2016, Oncotarget.

[19]  S. T. Mees,et al.  SERPINB5 Promoter Hypomethylation Differentiates Pancreatic Ductal Adenocarcinoma From Pancreatitis , 2016, Pancreas.

[20]  Hae Kyung Im,et al.  Survey of the Heritability and Sparse Architecture of Gene Expression Traits across Human Tissues , 2016, bioRxiv.

[21]  Kaanan P. Shah,et al.  A gene-based association method for mapping traits using reference transcriptome data , 2015, Nature Genetics.

[22]  Manal M. Hassan,et al.  Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer , 2015, Nature Genetics.

[23]  M. Raimondo,et al.  New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice , 2015, Clinical Cancer Research.

[24]  Yusuke Nakamura,et al.  Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer , 2014, Nature Genetics.

[25]  Youping Deng,et al.  Commonality and differences of methylation signatures in the plasma of patients with pancreatic cancer and colorectal cancer , 2014, International journal of cancer.

[26]  Benjamin D. Smith,et al.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. , 2014, Cancer research.

[27]  Rafael A. Irizarry,et al.  Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays , 2014, Bioinform..

[28]  Nicholas G Martin,et al.  Contribution of genetic variation to transgenerational inheritance of DNA methylation , 2014, Genome Biology.

[29]  Mark I. McCarthy,et al.  Global analysis of DNA methylation variation in adipose tissue from twins reveals links to disease-associated variants in distal regulatory elements. , 2013, American journal of human genetics.

[30]  Saurabh Baheti,et al.  SAAP-RRBS: streamlined analysis and annotation pipeline for reduced representation bisulfite sequencing , 2012, Bioinform..

[31]  O. Delaneau,et al.  A linear complexity phasing method for thousands of genomes , 2011, Nature Methods.

[32]  Joseph K. Pickrell,et al.  DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines , 2011, Genome Biology.

[33]  Wei Zheng,et al.  A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33 , 2010, Nature Genetics.

[34]  Geoffrey S. Tobias,et al.  Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer , 2009, Nature Genetics.

[35]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[36]  S. Chanock,et al.  ABO blood group and the risk of pancreatic cancer. , 2009, Journal of the National Cancer Institute.

[37]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[38]  D. Tosi,et al.  Unexpected distribution of CA19.9 and other type 1 chain Lewis antigens in normal and cancer tissues of colon and pancreas: Importance of the detection method and role of glycosyltransferase regulation. , 2017, Biochimica et biophysica acta. General subjects.